Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases
暂无分享,去创建一个
Siobhan M. Dolan | J. Ioannidis | P. Burton | J. Ostell | N. Rothman | S. Chanock | M. García-Closas | P. Vineis | M. Khoury | D. Seminara | T. Rebbeck | D. Winn | A. Janssens | M. Gwinn | J. Little | I. Fortier | T. O'Brien | J. Higgins | P. Boffetta | L. Bertram | H. Campbell | R. Pagon | R. Owen | Weisen Yu | A. Butterworth | J. Bernstein | H. Furberg | S. Dolan | A. Chockalingam | M. Khoury | J. Little
[1] J. Ioannidis,et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. , 2009, Journal of the National Cancer Institute.
[2] Jon Wakefield,et al. Bayes factors for genome‐wide association studies: comparison with P‐values , 2009, Genetic epidemiology.
[3] Christian Gieger,et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.
[4] J. Ioannidis,et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement , 2009, European Journal of Epidemiology.
[5] J. Ioannidis. Calibration of credibility of agnostic genome‐wide associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[6] J. Ioannidis. Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.
[7] S. Nelson,et al. Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays , 2008, PLoS genetics.
[8] John P A Ioannidis,et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.
[9] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[10] M. Daly,et al. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.
[11] Francis S Collins,et al. A HapMap harvest of insights into the genetics of common disease. , 2008, The Journal of clinical investigation.
[12] A. Singleton,et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.
[13] M. McCarthy,et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.
[14] W. Willett,et al. Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.
[15] M. Khoury,et al. A navigator for human genome epidemiology , 2008, Nature Genetics.
[16] Siobhan M. Dolan,et al. Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.
[17] C. Hoggart,et al. Genome‐wide significance for dense SNP and resequencing data , 2008, Genetic epidemiology.
[18] S. Kingsmore,et al. Genome-wide association studies: progress and potential for drug discovery and development , 2008, Nature Reviews Drug Discovery.
[19] John P A Ioannidis,et al. Required sample size and nonreplicability thresholds for heterogeneous genetic associations , 2008, Proceedings of the National Academy of Sciences.
[20] Muin J. Khoury,et al. Letting the genome out of the bottle--will we get our wish? , 2008, The New England journal of medicine.
[21] Ncbi. National Center for Biotechnology Information , 2008 .
[22] Positively disruptive , 2008, Nature Genetics.
[23] Nikolaos A Patsopoulos,et al. Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.
[24] Evangelos Evangelou,et al. Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.
[25] Jon Wakefield,et al. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.
[26] Eric J Topol,et al. The genomics gold rush. , 2007, JAMA.
[27] P. Donnelly,et al. Replicating genotype–phenotype associations , 2007, Nature.
[28] John P.A. Ioannidis,et al. Non-Replication and Inconsistency in the Genome-Wide Association Setting , 2007, Human Heredity.
[29] M. McCarthy,et al. Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.
[30] J. Ioannidis,et al. An exploratory test for an excess of significant findings , 2007, Clinical trials.
[31] M. Jarvelin,et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.
[32] J. Pritchard,et al. Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.
[33] R. Cotton. Recommendations of the 2006 Human Variome Project meeting , 2007, Nature Genetics.
[34] N. Rothman,et al. Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. , 2007, International journal of epidemiology.
[35] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[36] Roger M Harbord,et al. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.
[37] Roberta A Pagon,et al. GeneTests: an online genetic information resource for health care providers. , 2006, Journal of the Medical Library Association : JMLA.
[38] M. Khoury,et al. Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.
[39] A. Zlotta. NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses , 2006 .
[40] Emily Waltz,et al. US ponders unlocking the gates to prisoner research , 2006, Nature medicine.
[41] K. Vogan. Embracing risk , 2006, Nature Genetics.
[42] Paolo Vineis,et al. A road map for efficient and reliable human genome epidemiology , 2006, Nature Genetics.
[43] Paolo Vineis,et al. A network of investigator networks in human genome epidemiology. , 2005, American journal of epidemiology.
[44] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[45] Nathaniel Rothman,et al. Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .
[46] B. Charlesworth,et al. A polygenic basis for late-onset disease. , 2003, Trends in genetics : TIG.
[47] C. Mangano. Risky business. , 2003, The Journal of thoracic and cardiovascular surgery.
[48] Joshua M. Stuart,et al. Integrating genotype and phenotype information: an overview of the PharmGKB project , 2001, The Pharmacogenomics Journal.
[49] R. Elston,et al. Ascertainment adjustment: where does it take us? , 2000, American journal of human genetics.
[50] M. Khoury,et al. The Human Genome Epidemiology Network. , 1998, American journal of epidemiology.
[51] W. Raub. From the National Institutes of Health. , 1990, JAMA.